Livtencity

Livtencity (Maribavir) is an antiviral medication used to treat cytomegalovirus (CMV) infections. This oral medication is designed to help manage CMV in specific patient populations.

Livtencity is primarily used for the treatment of cytomegalovirus (CMV) infections. It is often prescribed for patients who have not responded well to other antiviral treatments. The medication works by targeting the virus to reduce its ability to replicate, thereby helping to manage the infection.

Common effects of Livtencity may include gastrointestinal issues such as nausea, diarrhea, and vomiting. Some patients may also experience changes in taste or appetite. These effects vary from person to person and are not experienced by everyone who takes the medication.

Livtencity should be handled with care, especially by individuals with pre-existing liver or kidney conditions. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Livtencity may interact with other medications, particularly those that are metabolized by the liver. It is important to discuss all current medications with a healthcare provider to ensure safe use. Avoid consuming alcohol while taking Livtencity, as it may exacerbate side effects.